Unrestricted use of 2 new-generation drug-eluting stents in patients with acute myocardial infarction: A propensity score-matched analysis

JACC: Cardiovascular Interventions

Volumn 5, Issue 9, 2012, Pages 936-945

  Chen, Kang Yin ^a,b   Rha, Seung Woon ^b   Wang, Lin ^c   Li, Yong Jian ^d   Li, Guang Ping ^a   Poddar, Kanhaiya L ^a   Park, Ji Young ^e   Choi, Cheol Ung ^b   Park, Chang Gyu ^b   Seo, Hong Seog ^b   Oh, Dong Joo ^b   Jeong, Myung Ho ^f   Ahn, Young Keun ^f   Hong, Taek Jong ^g   Kim, Young Jo ^h   Hur, Seung Ho ⁱ   Seong, In Whan ^j   Chae, Jei Keon ^k   Cho, Myeong Chan ^k   Bae, Jang Ho ^l   Choi, Dong Hoon ^m   Jang, Yang Soo ^m   Chae, In Ho ⁿ   Kim, Chong Jin ^o   Yoon, Jung Han ^p   Chung, Wook Sung ^q   Seung, Ki Bae ^q   Park, Seung Jung ^r   more..

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^b Korea University College of Medicine   (South Korea)

^c TIANJIN CHEST HOSPITAL   (China)

^d TIANJIN NANKAI HOSPITAL   (China)

^e Eulji General Hospital   (South Korea)

^f Chonnam National University Medical School   (South Korea)

^g Pusan National University School of Medicine   (South Korea)

^h Young Nam University Hospital   (South Korea)

ⁱ Dongsan Medical Center   (South Korea)

^j Chungnam National University College of Medicine   (South Korea)

^k Chonbuk National University Medical School   (South Korea)

^l Konyang University   (South Korea)

^m Yonsei University   (South Korea)

ⁿ Seoul National University Bundang Hospital   (South Korea)

^o Kyung Hee University College of Medicine   (South Korea)

^p Wonju Severance Christian Hospital   (South Korea)

^q The Catholic University of Korea   (South Korea)

^r Asan Medical Center   (South Korea)

more..

Author keywords

acute myocardial infarction; everolimus eluting stents; percutaneous coronary intervention; zotarolimus eluting stents

Indexed keywords

ENDEAVOR SPRINT; EVEROLIMUS; UNCLASSIFIED DRUG; ZOTAROLIMUS;

ACUTE HEART INFARCTION; ADULT; ANGIOGRAPHY; ARTICLE; DRUG ELUTING STENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARAMETERS; PRIORITY JOURNAL; PROPENSITY SCORE; REGISTER; REVASCULARIZATION; SAFETY; SOUTH KOREA; STENT THROMBOSIS; TARGET LESION FAILURE; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECURRENCE; REGISTRIES; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84866376186     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2012.05.009     Document Type: Article

References (27)

1. G.W. Stone, S.G. Ellis, D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231 (Pubitemid 38067635)
2. D.R. Holmes Jr., D.J. Kereiakes, S. Garg Stent thrombosis J Am Coll Cardiol 56 2010 1357 1365
3. S. Cook, E. Ladich, G. Nakazawa Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis Circulation 120 2009 391 399
4. D.E. Kandzari, M.B. Leon, J.J. Popma Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial J Am Coll Cardiol 48 2006 2440 2447 (Pubitemid 44881222)
5. M.B. Leon, L. Mauri, J.J. Popma A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial J Am Coll Cardiol 55 2010 543 554
6. M.B. Leon, E. Nikolsky, D.E. Cutlip Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial J Am Coll Cardiol Intv 3 2010 1043 1050
7. E. Kedhi, K.S. Joesoef, E. McFadden Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
8. G.W. Stone, A. Rizvi, K. Sudhir Randomized comparison of everolimus- and paclitaxel-eluting stents 2-Year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial J Am Coll Cardiol 58 2011 19 25
9. K.Y. Chen, S.W. Rha, Y.J. Li Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Circulation 119 2009 3207 3214
10. D.E. Cutlip, S. Windecker, R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
11. P.W. Serruys, P. Ruygrok, J. Neuzner A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial EuroIntervention 2 2006 286 294
12. G.W. Stone, M. Midei, W. Newman Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial JAMA 299 2008 1903 1913 (Pubitemid 351574920)
13. J. Fajadet, W. Wijns, G.J. Laarman Randomized, double-blind, multicenter study of the endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial Circulation 114 2006 798 806 (Pubitemid 44268230)
14. J.A. Herrador, J.C. Fernandez, M. Guzman, V. Aragon Comparison of zotarolimus- versus everolimus-eluting stents in the treatment of coronary bifurcation lesions Catheter Cardiovasc Interv 78 2011 1086 1092
15. G.A. Sgueglia, F. Burzotta, C. Trani Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry Catheter Cardiovasc Interv 77 2011 503 509
16. K. Wakabayashi, C. Delhaye, M. Mahmoudi Impact of drug-eluting stent type on periprocedural myocardial necrosis EuroIntervention 7 2011 136 142
17. P.W. Serruys, S. Silber, S. Garg Comparison of zotarolimus-eluting and everolimus-eluting coronary stents N Engl J Med 363 2010 136 146
18. S. Silber, S. Windecker, P. Vranckx, P.W. Serruys RESOLUTE All Comers Investigators Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE all comers trial Lancet 377 2011 1241 1247
19. A.C. Yeung, M.B. Leon, A. Jain Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial J Am Coll Cardiol 57 2011 1778 1783
20. J.M. de la Torre Hernandez, F. Alfonso, F. Gimeno Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2 (estudio Espanol sobre trombosis de stents Farmacoactivos de segunda generacion-2) J Am Coll Cardiol Intv 3 2010 911 919
21. D. Planer, P.C. Smits, D.J. Kereiakes Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A clinical evaluation of the XIENCE V everolimus eluting coronary Stent system) and COMPARE (A trial of everolimus-eluting stents and paclitaxel-eluting stents for coronary revascularization in daily practice) trials J Am Coll Cardiol Intv 4 2011 1104 1115
22. A.L. Bartorelli, P.W. Serruys, K. Miquel-Hébert, S. Yu, W. Pierson, G.W. Stone An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: a pooled analysis from the SPIRIT II and SPIRIT III trials Catheter Cardiovasc Interv 76 2010 60 66
23. G.W. Stone, A. Rizvi, K. Sudhir Randomized comparison of everolimus- and paclitaxel-eluting stents 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial J Am Coll Cardiol 58 2011 19 25
24. U. Baber, R. Mehran, S.K. Sharma Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials J Am Coll Cardiol 58 2011 1569 1577
25. B.E. Claessen, R. Mehran, G.S. Mintz Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents J Am Coll Cardiol Intv 4 2011 974 981
26. S.W. Lee, S.W. Park, M.K. Hong Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis J Am Coll Cardiol 46 2005 1833 1837
27. M. Joner, G. Nakazawa, A.V. Finn Endothelial cell recovery between comparator polymer-based drug-eluting stents J Am Coll Cardiol 52 2008 333 342 (Pubitemid 352001347)